Update on morphea

Hunzelmann, 1997, Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma, J Am Acad Dermatol, 36, 433, 10.1016/S0190-9622(97)80221-6 Hulshof, 2000, Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma, J Am Acad Dermatol, 43, 1017, 10.1067/mjd.2000.108369 Kreuter, 2006, A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma, J Am Acad Dermatol, 54, 440, 10.1016/j.jaad.2005.11.1063 Kroft, 2009, Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study, Am J Clin Dermatol, 10, 181, 10.2165/00128071-200910030-00004 Steen, 1982, D-Penicillamine therapy in progressive systemic sclerosis (scleroderma): a retrospective analysis, Ann Intern Med, 97, 652, 10.7326/0003-4819-97-5-652 Clements, 1995, Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis, J Rheumatol, 22, 1281 Pope, 1995, Variability of skin scores and clinical measurements in scleroderma, J Rheumatol, 22, 1271 Zachariae, 1994, Skin scoring in systemic sclerosis: a modification—relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP), Acta Derm Venereol, 74, 444 Kreuter, 2005, Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma, Arch Dermatol, 141, 847, 10.1001/archderm.141.7.847 Kreuter, 2001, Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea, Pediatr Dermatol, 18, 241, 10.1046/j.1525-1470.2001.018003241.x Seyger, 1997, Reliability of two methods to assess morphea: skin scoring and the use of a durometer, J Am Acad Dermatol, 37, 793, 10.1016/S0190-9622(97)70121-X Seyger, 1998, Low-dose methotrexate in the treatment of widespread morphea, J Am Acad Dermatol, 39, 220, 10.1016/S0190-9622(98)70079-9 Arkachaisri, 2009, The localized scleroderma skin severity index and physician global assessment of disease activity: a work in progress toward development of localized scleroderma outcome measures, J Rheumatol, 36, 2819, 10.3899/jrheum.081284 Arkachaisri, 2010, Development and initial validation of the localized scleroderma skin damage index and physician global assessment of disease damage: a proof-of-concept study, Rheumatology (Oxford), 49, 373, 10.1093/rheumatology/kep361 Albrecht, 2005, The CLASI (Cutaneous Lupus Erythematosus Disease Area and Severity Index): an outcome instrument for cutaneous lupus erythematosus, J Invest Dermatol, 125, 889, 10.1111/j.0022-202X.2005.23889.x Zulian, 2007, A new computerized method for the assessment of skin lesions in localized scleroderma, Rheumatology (Oxford), 46, 856, 10.1093/rheumatology/kel446 Andres, 2010, Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study, Br J Dermatol, 162, 445, 10.1111/j.1365-2133.2009.09438.x de Rie, 2003, Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method, Dermatology, 207, 298, 10.1159/000073093 Birdi, 1992, Childhood linear scleroderma: a possible role of thermography for evaluation, J Rheumatol, 19, 968 Martini, 2002, Juvenile-onset localized scleroderma activity detection by infrared thermography, Rheumatology (Oxford), 41, 1178, 10.1093/rheumatology/41.10.1178 Bendeck, 2007, Ultrasound as an outcome measure to assess disease activity in disorders of skin thickening: an example of the use of radiologic techniques to assess skin disease, Dermatol Ther, 20, 86, 10.1111/j.1529-8019.2007.00116.x Jacobe, 2007, Understanding clinical trial outcomes: design, analysis, and interpretation, Dermatol Ther, 20, 77, 10.1111/j.1529-8019.2007.00115.x Li, 2009, The use of Doppler ultrasound to evaluate lesions of localized scleroderma, Curr Rheumatol Rep, 11, 205, 10.1007/s11926-009-0028-y Li, 2007, Ultrasonography is a sensitive tool for monitoring localized scleroderma, Rheumatology (Oxford), 46, 1316, 10.1093/rheumatology/kem120 Hoffmann, 1991, 20-MHz B-mode ultrasound in monitoring the course of localized scleroderma (morphea), Acta Derm Venereol Suppl (Stockh), 164, 3 Kerscher, 1996, PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients, Arch Dermatol, 132, 1280, 10.1001/archderm.1996.03890350014001 Kerscher, 1998, Low-dose UVA phototherapy for treatment of localized scleroderma, J Am Acad Dermatol, 38, 21, 10.1016/S0190-9622(98)70533-X Stege, 1997, High-dose UVA1 radiation therapy for localized scleroderma, J Am Acad Dermatol, 36, 938, 10.1016/S0190-9622(97)80277-0 Serup, 1984, Decreased skin thickness of pigmented spots appearing in localized scleroderma (morphoea). Measurement of skin thickness by 15 MHz pulsed ultrasound, Arch Dermatol Res, 276, 135, 10.1007/BF00511074 Serup, 1984, Localized scleroderma (morphoea): thickness of sclerotic plaques as measured by 15 MHz pulsed ultrasound, Acta Derm Venereol, 64, 214 Kroft, 2009, Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study, Br J Dermatol, 160, 1075, 10.1111/j.1365-2133.2008.09017.x Weibel, 2006, Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children, Br J Dermatol, 155, 1013, 10.1111/j.1365-2133.2006.07497.x Fitch, 2006, Treatment of pediatric localized scleroderma with methotrexate, J Rheumatol, 33, 609 Cox, 2008, Juvenile localised scleroderma: a retrospective review of response to systemic treatment, Ir J Med Sci, 177, 343, 10.1007/s11845-008-0217-0 Uziel, 2000, Methotrexate and corticosteroid therapy for pediatric localized scleroderma, J Pediatr, 136, 91, 10.1016/S0022-3476(00)90056-8 Kerscher, 1994, Treatment of localised scleroderma with PUVA bath photochemotherapy, Lancet, 343, 1233, 10.1016/S0140-6736(94)92449-X Kerscher, 1995, Treatment of localised scleroderma by UVA1 phototherapy, Lancet, 346, 1166, 10.1016/S0140-6736(95)91843-4 Morita, 2000, Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis, J Am Acad Dermatol, 43, 670, 10.1067/mjd.2000.105165 Grabbe, 1996, High-dose ultraviolet A1 (UVA1), but not UVA/UVB therapy, decreases IgE-binding cells in lesional skin of patients with atopic eczema, J Invest Dermatol, 107, 419, 10.1111/1523-1747.ep12363402 Kroft, 2008, Period of remission after treatment with UVA-1 in sclerodermic skin diseases, J Eur Acad Dermatol Venereol, 22, 839, 10.1111/j.1468-3083.2007.02576.x El-Mofty, 2004, Suggested mechanisms of action of UVA phototherapy in morphea: a molecular study, Photodermatol Photoimmunol Photomed, 20, 93, 10.1111/j.1600-0781.2004.00080.x Jacobe, 2008, UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V, Br J Dermatol, 159, 691, 10.1111/j.1365-2133.2008.08672.x Wang, 2008, Effect of increased pigmentation on the antifibrotic response of human skin to UV-A1 phototherapy, Arch Dermatol, 144, 851, 10.1001/archderm.144.7.851 Gruss, 1997, Induction of interstitial collagenase (MMP-1) by UVA-1 phototherapy in morphea fibroblasts, Lancet, 350, 1295, 10.1016/S0140-6736(05)62472-5 Gruss, 2001, Effects of low dose ultraviolet A-1 phototherapy on morphea, Photodermatol Photoimmunol Photomed, 17, 149, 10.1034/j.1600-0781.2001.170401.x Sator, 2009, Medium-dose is more effective than low-dose ultraviolet A1 phototherapy for localized scleroderma as shown by 20-MHz ultrasound assessment, J Am Acad Dermatol, 60, 786, 10.1016/j.jaad.2008.12.013 Usmani, 2008, Photochemotherapy for localized morphoea: effect on clinical and molecular markers, Clin Exp Dermatol, 33, 698, 10.1111/j.1365-2230.2008.02890.x El-Mofty, 2000, Low-dose broad-band UVA in morphea using a new method for evaluation, Photodermatol Photoimmunol Photomed, 16, 43, 10.1034/j.1600-0781.2000.d01-1.x El-Mofty, 2004, Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis, Photodermatol Photoimmunol Photomed, 20, 148, 10.1111/j.1600-0781.2004.00081.x Falanga, 1990, D-penicillamine in the treatment of localized scleroderma, Arch Dermatol, 126, 609, 10.1001/archderm.1990.01670290053007 Martini, 2009, Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil, Rheumatology (Oxford), 48, 1410, 10.1093/rheumatology/kep244 Roos, 2007, In vitro evidence for a direct antifibrotic role of the immunosuppressive drug mycophenolate mofetil, J Pharmacol Exp Ther, 321, 583, 10.1124/jpet.106.117051 Shimizu, 2004, Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation, Transplantation, 77, 1661, 10.1097/01.TP.0000127592.13707.B6 Gao, 2006, The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways, Transplant Proc, 38, 2154, 10.1016/j.transproceed.2006.06.006 Derk, 2009, A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis, Rheumatology (Oxford), 48, 1595, 10.1093/rheumatology/kep295 Strauss, 2004, Good response of linear scleroderma in a child to ciclosporin, Br J Dermatol, 150, 790, 10.1111/j.0007-0963.2004.05901.x Crespo, 2009, Rapid response to cyclosporine and maintenance with methotrexate in linear scleroderma in a young girl, Pediatr Dermatol, 26, 118, 10.1111/j.1525-1470.2008.00848.x Knobler, 2006, A randomized, double-blind, placebo-controlled trial of photopheresis in systemic sclerosis, J Am Acad Dermatol, 54, 793, 10.1016/j.jaad.2005.11.1091 Neustadter, 2009, Extracorporeal photochemotherapy for generalized deep morphea, Arch Dermatol, 145, 127, 10.1001/archdermatol.2008.547 Dytoc, 2005, First case series on the use of imiquimod for morphoea, Br J Dermatol, 153, 815, 10.1111/j.1365-2133.2005.06776.x Dytoc, 2007, First case series on the use of calcipotriol-betamethasone dipropionate for morphoea, Br J Dermatol, 157, 615, 10.1111/j.1365-2133.2007.07971.x Cunningham, 1998, Topical calcipotriene for morphea/linear scleroderma, J Am Acad Dermatol, 39, 211, 10.1016/S0190-9622(98)70077-5 Batchelor, 2008, Photodynamic therapy for the treatment of morphoea, Clin Exp Dermatol, 33, 661, 10.1111/j.1365-2230.2008.02873.x Buckley, 1993, Focal scleroderma in children: an orthopaedic perspective, J Pediatr Orthop, 13, 784, 10.1097/01241398-199311000-00020 Hunzelmann, 1998, Management of localized scleroderma, Semin Cutan Med Surg, 17, 34, 10.1016/S1085-5629(98)80060-6 Shekelle, 1999, Clinical guidelines: developing guidelines, BMJ, 318, 593, 10.1136/bmj.318.7183.593